Woodline Partners »

Alto Neuroscience shares owned by Woodline Partners

Quarter-by-quarter ownership of Alto Neuroscience shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Alto Neuroscience

Tip: Access up to 7 years of quarterly data

All positions including Alto Neuroscience held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alto Neuroscience by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.9M 125k 15.35

More positions owned by Woodline Partners

Eli Lilly & Co. (LLY)
Te Connectivity SHS (TEL)
Regeneron Pharmaceuticals (REGN)
Encana Corporation (OVV)
Analog Devices (ADI)
Avnet (AVT)
Merck & Co (MRK)
Revolution Medicines (RVMD)
Zimmer Holdings (ZBH)
Meta Platforms Cl A (META)
Roivant Sciences SHS (ROIV)
Abbvie (ABBV)
Enerplus Corp (ERF)
Permian Resources Corp Class A Com (PR)
Amazon (AMZN)

View all positions for Woodline Partners

Top funds holding Alto Neuroscience

FMR
RA Capital Management
Point72 Asset Management
72 Investment Holdings
T. Rowe Price Associates
Franklin Resources
ExodusPoint Capital Management
Vanguard Group
Jennison Associates
Artal Group
Board of Trustees of The Leland Stanford Junior University
AWM Investment Company
Citadel Advisors
Valor Management
BlackRock

View all funds holding Alto Neuroscience